Editas Medicine, Inc. financial data

Symbol
EDIT on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 314% % -28%
Debt-to-equity 344% % 501%
Return On Equity -349% % -335%
Return On Assets -79% % -54%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97,618,660 shares 18%
Common Stock, Shares, Outstanding 93,264,421 shares 13%
Entity Public Float $383,847,152 USD -43%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 90,090,397 shares 9.2%
Weighted Average Number of Shares Outstanding, Diluted 90,090,397 shares 9.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $46,384,000 USD -25%
Research and Development Expense $111,160,000 USD -50%
General and Administrative Expense $54,904,000 USD -22%
Operating Income (Loss) $198,847,000 USD 13%
Nonoperating Income (Expense) $988,000 USD -106%
Net Income (Loss) Attributable to Parent $199,835,000 USD 5.1%
Earnings Per Share, Basic -2 USD/shares 5.9%
Earnings Per Share, Diluted -2 USD/shares 5.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $165,648,000 USD 73%
Marketable Securities, Current $0 USD -100%
Assets, Current $176,891,000 USD -35%
Property, Plant and Equipment, Net $4,287,000 USD -72%
Operating Lease, Right-of-Use Asset $17,583,000 USD -51%
Other Assets, Noncurrent $2,990,000 USD -43%
Assets $201,751,000 USD -38%
Accounts Payable, Current $3,163,000 USD -75%
Employee-related Liabilities, Current $6,158,000 USD -48%
Accrued Liabilities, Current $47,522,000 USD 65%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $61,773,000 USD -15%
Contract with Customer, Liability, Noncurrent $54,204,000 USD 0%
Operating Lease, Liability, Noncurrent $13,564,000 USD -39%
Other Liabilities, Noncurrent $4,688,000 USD 43%
Liabilities $188,298,000 USD 24%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $1,622,883,000 USD -14%
Stockholders' Equity Attributable to Parent $13,453,000 USD -92%
Liabilities and Equity $201,751,000 USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $47,799,000 USD 4.2%
Net Cash Provided by (Used in) Financing Activities $1,437,000 USD -848%
Net Cash Provided by (Used in) Investing Activities $56,387,000 USD
Common Stock, Shares Authorized 390,000,000 shares 100%
Common Stock, Shares, Issued 93,264,421 shares 13%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $7,151,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $168,318,000 USD 69%
Deferred Tax Assets, Valuation Allowance $388,967,000 USD 18%
Deferred Tax Assets, Gross $397,454,000 USD 18%
Operating Lease, Liability $35,032,000 USD -4.1%
Depreciation $1,917,000 USD 36%
Payments to Acquire Property, Plant, and Equipment $114,000 USD -94%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $200,357,000 USD 4%
Lessee, Operating Lease, Liability, to be Paid $39,947,000 USD -8.1%
Property, Plant and Equipment, Gross $31,834,000 USD -31%
Operating Lease, Liability, Current $6,088,000 USD -63%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,728,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year One $17,143,000 USD 15%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,915,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,076,000 USD -0.81%
Deferred Tax Assets, Operating Loss Carryforwards $170,770,000 USD 11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $15,679,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,000,000 USD -15%
Operating Lease, Payments $5,406,000 USD 41%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $8,487,000 USD -7.6%
Share-based Payment Arrangement, Expense $11,891,000 USD -48%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%